In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-23 of 23 for your search:
Drug:  peginterferon alfa-2b
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV
Type: Treatment
Status: Closed
Age: 25 to 75
Sponsor: Other
Protocol IDs: O2006-415, NCT00375661
2.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 to 70
Sponsor: Pharmaceutical / Industry
Protocol IDs: SPRI-C98-026, SPRI-C98-026-054, SPRI-I98-026
3.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: P04831, NCT00457418
4.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 5 to 40 at diagnostic biopsy
Sponsor: NCI, Other
Protocol IDs: CDR0000438714, COG-AOST0331, ISRCTN67613327, EU-20530, MRC-EURAMOS1, MRC-BO08, EUDRACT-2004-000242-20, AOST0331, NCT00134030
5.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSKCC-01143, NCI-G-02-2102, NCT00045279
6.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000258114, ECOG-2602, E2602, NCT00049530
7.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: 030002, 03-C-0002, NCI-03-C-0002, NABTC-0201, NCT00052650, NCT00047879
8.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02519, MDA-ID-02063, N01CM62202, CDR0000271225, NCI-4772, 4772, NCT00055809
9.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000378049, MUSC-100614, CELGENE-MUSC-100614, MUSC-HR-10423, NCT00090870
10.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSKCC-02033A
11.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000441020, MDA-ID-01450, ID01-450, NCT00276523
12.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000445593, P30CA022453, WSU-C-2257, WSU-HIC-120900M01-FB, NCT00238329
13.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2006-0360, NCT00415857
14.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000540598, P30CA093373, CCC-PHII-40, ZENECA-AZ1839US/0227, UCD-200412338-4, UCD-ZD1839, PHII-40, NCT00467077
15.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2005-0143, NCT00525031
16.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 21 and under
Sponsor: Other
Protocol IDs: MEL06, NCT00539591
17.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: DeCOG SoraPeg 2007, EudraCT 2007-001918-16, NCT00623402
18.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 19 and over
Sponsor: Other
Protocol IDs: USA-MCI-01, IND# 13647, NCT00746746
19.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000068523, P30CA023108, DMS-0010, NCI-G01-1924, NCT00014261
20.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2009-00295, NVCI 07-25, R21CA122270, CDR0000597624, 8224, NCT00701298
21.

Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2006-0816, NCT00861406
22.

Phase: No phase specified
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: ID02-534, NCT00050531
23.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: EPROST-20070805, SCCC-2007055, NCT00854581
New Search